Ten Polymorphisms of Estrogen-Metabolizing Genes and a Family History of Colon Cancer—An Association Study of Multiple Gene-Gene Interactions

Abstract

Estrogen replacement therapy is associated with a reduced risk of colon cancer. Therefore, we evaluated the following ten estrogen metabolism-associated single-nucleotide polymorphisms (SNPs) by sequencing-on-chip technology using solid-phase polymerase chain reaction (PCR) on oligonucleotide microarrays: catechol-O-methyltransferase (COMT) Val158Met G→A, 17-beta-hydroxysteroid dehydrogenase type 1 (HSD17) vlV A→C, cytochrome P-450 (CYP) 17 A2 allele T→C, CYP1A1 MspI RFLP f→C, CYP1A1 Ile462Val A→G, CYP19 Arg264Cys C→T, CYP19 C1558T C→T, CYP 1B1 Leu432Val, CYP1B1 Asn453Ser, and estrogen receptor (ER) alpha IVS1 - 401→C in 76 patients with a family history of colon cancer and 722 healthy controls. Using stepwise logistic regression models, we found that none of the investigated SNPs is associated with a family history of colon cancer in a univariate and multivariate logistic regression model. In addition, when all two-way interactions of the investigated SNPs were ascertained, no significant interactions between SNPs were observed. In conclusion, we found no association between the carriage of one or multiple SNPs of the estrogen metabolism and a family history of colon cancer.

Keywords

Estrogen gene polymorphism microarray risk factor

References

1. American Cancer Society . Cancer facts and figures. Atlanta, GA: American Cancer Society, 2003.

2. de la Chapelle A . Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004;4:769-780.

3. Gong Z , Xie D , Deng Z , et al. The PPAR γ Pro12Ala polymorphism and risk for incident sporadic colorectal adenomas. Carcinogenesis 2005;26(3):579-585.

4. Tamer L , Ercan B , Ates NA , et al. N-acetyltransferase 2 gene polymorphism in patients with colorectal carcinoma. Cell Biochem Funct Dec 22, 2004 [Epub ahead of print].

5. Slattery ML , Murtaugh M , Caan B , Ma KN , Wolff R , Samowitz W . Associations between BMI, energy intake, energy expenditure, VDR genotype and colon and rectal cancers (United States). Cancer Causes Control 2004;15:863-872.

6. Anderson GL , Limacher M , Assaf AR , et al. Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-1712.

7. Rossouw JE , Anderson GL , Prentice RL , et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.

8. Caan BJ , Coates AO , Slattery ML , et al. Body size and the risk of colon cancer in a large case-control study. Int J Obes Relat Metab Disord 1998;22:178-184.

9. Hou L , Ji BT , Blair A , Dai Q , Gao YT , Chow WH . Commuting physical activity and risk of colon cancer in Shanghai, China. Am J Epidemiol 2004;160:860-867.

10.

10. Tempfer C , Schneeberger C , Huber JC . Applications of polymorphisms and pharmacogenomics in obstetrics and gynecology. Pharmacogenomics 2004;5:57-65.

11.

11. Huber M , Mundlein A , Dornstauder E , et al. Accessing single nucleotide polymorphisms in genomic DNA by direct multiplex polymerase chain reaction amplification on oligonucleotide microarrays. Anal Biochem 2002;303:25-33.

12.

12. Khoury MJ , McCabe LL , McCabe ER . Population screening in the age of genomic medicine. N Engl J Med 2003;348:50-58.

13.

13. Brockmoller J , Cascorbi I , Henning S , Meisel C , Roots I . Molecular genetics of cancer susceptibility. Pharmacology 2002;61:212-227.